Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
ECO
Apr 12, 2024, 05:40 |
Insight
Rajkumar Venkatramani: I got rejected and it was the best thing that happened to me
Rajkumar Venkatramani, Section Chief of Oncology at Texas Children’s Hospital, shared a post on LinkedIn: "I…
Apr 12, 2024, 05:16 |
Drugs
Tanja Obradovic: Era of antibody drug conjugates just got even more exciting with the first tumor-agnostic approval for ADC
Tanja Obradovic, Vice President of Oncology Scientific Affairs at ICON, recently shared on LinkedIn: "Era…
Apr 12, 2024, 03:19 |
Dialogues
OncoInfluencers: Dialogue with Pasi Jänne, hosted by Gevorg Tamamyan
Join us for an exciting new episode of “OncoInfluencers,” hosted by Dr. Gevorg Tamamyan. In…
Apr 11, 2024, 17:27 |
Career
Jon Lim: Big thanks Pezcoller Foundation for the AACR-Pezcoller Foundation Scholar-in-Training Award
Jon Lim, Medical Oncologist and Postdoctoral Clinical Fellow at The Francis Crick Institute, shared a…
Apr 11, 2024, 17:19 |
Blog
Fumiko Ladd Chino: Pro tip to help the patients feel about what the next steps are
Fumiko Ladd Chino shared on X/Twitter: "Pro tip that bears repeating. If you are someone…
Apr 11, 2024, 17:02 |
Blog
Chiquita Brooks-LaSure: We are committed to Biden Cancer Moonshot goal to prevent cancer before it starts
Chiquita Brooks-LaSure, Administrator of Medicare and Medicaid Services, shared on X/Twitter: "For National Cancer Prevention and…
Apr 11, 2024, 16:58 |
Blog
Drew Moghanaki: Why programs that focus on lung health are very effective
Drew Moghanaki, Lung Cancer Specialist at UCLA Health Jonsson Cancer Center, shared a post on…
Apr 11, 2024, 14:59 |
Blog
Olya Kudinenko: I am stepping down from the operational management of the Tabletochki CF
Olya Kudinenko, Founder of Tabletochki CF and Kids-of-Ukraine.org, shared a post on LinkedIn: “I never…
Apr 11, 2024, 14:41 |
Drugs
Neil Grubert: Dramatic differences in access to Advanced Therapy Medicinal Products (ATMP) across Europe
Neil Grubert, Independent Global Market Access Consultant, shared on LinkedIn: “Dramatic differences in access to…
Apr 11, 2024, 14:28 |
Insight
New Paper Alert! Promising Results from Cabozantinib Phase 2 trial in advanced Adrenocortical Tumors
Promising Results from Cabozantinib Phase 2 trial in advanced Adrenocortical Tumors Authors: Matthew T Campbell,…
324
325
326
327
328
All:
4506
Posts:
3251 - 3260
OncoDaily Announces Strategic Partnership with the Asian Fund for Cancer Research Limited (AFCR)
Peyo the Therapy Horse: Comforting Terminally Ill Patients Through Horse Therapy.
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 3
Small Bowel Cancer: Symptoms & Causes, Types, Diagnosis and Treatment
Mikkael A. Sekeres, Candidate for Secretary of ASH
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube